A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension
Clinical trial NCT05314439 · COMPLETED
Trial details
- NCT number
- NCT05314439
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2023-01-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.